Prognostic Model Heart Failure

Status Recruiting

Clinical Trial Summary

This study aims to determine the prognosis of heart failure in our population by using multiple validated risk scores and to evaluate the strengths of these scores in assessing prognosis with better discrimination.

Clinical Trial Description

After fulfilling the eligibility criteria, informed consent will be obtained from all the patients regarding using data for research while maintaining anonymity. All the included patients will be interviewed by the assigned physician to complete the detailed questionnaire, including patient demographics, risk factors, and validated questionnaires including the Acute Decompensated Heart Failure National Registry (ADHERE), The Get With The Guideline-Heart Failure (GWTG-HF) Risk Score, the Ottawa Heart Failure Risk Scale (OHFRS), and EHMRG30-ST score. All the patients will be followed after 30 days, and survival status will be obtained. The AUC of the GWTG-HF risk score for all-cause death was 0.687 (95% CI, 0.649-0.725) [18], at 95% confidence interval, ±3% margin of error, the sample size was calculated to be n=626 patients. The calculated sample size was inflated by a factor of 1.5 for the design effect; hence, the sample size for the study will be N=939. For data verification, 10% of the data will be cross-checked with the source document (Patient file). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06414928
Study type	Observational [Patient Registry]
Source	National Institute of Cardiovascular Diseases, Pakistan
Contact	Madiha Fatima, MBBS, FCPS
Phone	+923452325663
Email	madihafatima89@hotmail.com
Status	Recruiting
Phase
Start date	February 14, 2024
Completion date	June 14, 2026

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04080388` - How to Prevent Heart Failure Readmission by Using Lung Impedance Device (HOPE-HF Study)	Phase 3
Recruiting	`NCT04751838` - Development and Validation of a Simple-to-use Nomogram for Predicting In-hospital Mortality in Acute Heart Failure Patients Undergoing Continuous Renal Replacement Therapy
Active, not recruiting	`NCT04618601` - Diuretic and Natriuretic Effect of High-dose Spironolactone in Patients With Acute Heart Failure	Phase 4
Recruiting	`NCT06142474` - SGLT2 Inhibitors in Patients With ADHF During Ventilator Weaning	Phase 3
Active, not recruiting	`NCT05603247` - The SWISSHEART Failure Network (SHFN)
Recruiting	`NCT03169803` - Cardiac Output Autonomic Stimulation Therapy for Acute Heart Failure (COAST-AHF)	N/A
Not yet recruiting	`NCT06273397` - Acetazolamide or Metolazone in Acute Heart Failure	N/A
Recruiting	`NCT03542123` - Cardiac Output Autonomic Stimulation Therapy for Heart Failure - Hemodynamic Effects	N/A
Completed	`NCT04878263` - Evaluation and Support Care Process Within the Care Pathway of Heart Failure Patients	N/A
Not yet recruiting	`NCT06442280` - SGLT-2 Inhibitor and High-Dose Furosemide Plus Small-Volume Hypertonic Saline Solution in Acute HF	Phase 4
Completed	`NCT04281849` - Balance, Aerobic Capacity, Mobility and Strength in Patients Hospitalized for Heart Failure (BAMS-HF) Program	N/A
Not yet recruiting	`NCT04403659` - Telemonitoring of Patients Admitted in Hospital at Home With Acute Decompensated Heart Failure - Pilot Study	N/A
Terminated	`NCT03574857` - Prospective Comparison of Metolazone Versus Chlorothiazide for Acute Decompensated Heart Failure With Diuretic Resistance	Phase 4
Completed	`NCT03136198` - B-lines Lung Ultrasound Guided ED Management of Acute Heart Failure Pilot Trial	Phase 2
Terminated	`NCT03746002` - Diuretic Effect of Metolazone Pre-dosing Versus Concurrent Dosing	Phase 4
Active, not recruiting	`NCT03513653` - Strain for Risk Assessment and Therapeutic Strategies in Patients With Acute Heart Failure (STRATS-AHF) Registry
Recruiting	`NCT06092437` - Investigating a Tailored Diuretic Algorithm in Acute Heart Failure Patients	N/A
Recruiting	`NCT05746923` - Lesser Poland Cracovian Heart Failure Registry
Completed	`NCT04606927` - Pragmatic Urinary Sodium-based Treatment algoritHm in Acute Heart Failure	N/A
Completed	`NCT03200860` - Effects of Empagliflozin on Clinical Outcomes in Patients With Acute Decompensated Heart Failure	Phase 2